Bqnat 100 mg (Bedaquiline)
| Active Ingredient | Bedaquiline |
|---|---|
| Indication: | MDR-TB |
| Manufacturer: | Natco Pharma Ltd. |
| Packaging | 188 Tablets in 1 Bottle |
| Strength | 100mg |
| Delivery Time | 6 To 15 days |
Bqnat 100 mg contains Bedaquiline, a novel antimycobacterial agent used in the treatment of multidrug-resistant tuberculosis (MDR-TB). Bedaquiline works by inhibiting the ATP synthase enzyme in Mycobacterium tuberculosis, which is essential for the bacteria’s energy production and survival.
Bqnat is reserved for use in adults and adolescents (≥18 years) diagnosed with pulmonary MDR-TB when other effective treatment options are not available. It is prescribed as part of a combination regimen alongside other second-line anti-TB drugs under strict medical supervision.








There are no reviews yet.